Biotechnology News VANTAS Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-2 out of 2 found

Current Search: vantas: 2

Indevus Receives Approvable Letter from FDA for NEBIDO(R)
Company Announces Revised Operating Plan to Respond to NEBIDO Delay LEXINGTON, Mass., June 30 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc.

today announced that it has received an approvable letter from the U.S.

Food and Drug...

KOTA Territory News: Jun 30 2008 4:56PM
Matching: vantas

Find similar documents

Indevus Pharma shares plunge on Nebido delay; analysts mixed
BOSTON (Thomson Financial) - Shares of Indevus Pharmaceuticals Inc.

plunged Wednesday after the Lexington, Mass.-based biotechnology company said it expects the Food and Drug Administration to formally request additional safety data prior...

Sharewatch: Jun 4 2008 3:41PM
Matching: vantas

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.